In addition, the hypothesis of an independent start of the Aβ and Tau pathology will corroborate the importance of developing an accurate tool for the in vivo detection of tauopathy, which may provide complementary information with respect to amyloid pathology in vivo assessment. The gene discussed is MAPT; the disease is tauopathy.